TY - JOUR
T1 - Decongestants and antihistamines for acute otitis media in children
AU - Brattström, Petter
AU - Moresco, Luca
AU - Nussbaumer-Streit, Barbara
AU - Bruschettini, Matteo
AU - Gisselsson-Solen, Marie
N1 - Funding Information:
The methods section of this protocol is based on a standard template developed by Cochrane Airways and adapted by Cochrane Acute Respiratory Infections. We thank Maria Björklund (Library and ICT services, Lund University) and Krister Aronsson (Library and ICT services, Lund University) for designing the literature searches. We thank Cochrane Consumers Melixa Medina-Aedo (Universitat Autònoma de Barcelona, Spain), Jenny Negus, Jennifer Larosa and Wendy Free (Quality Matters Safety Matters Pty Ltd, Logan, Queensland, Australia) for providing feedback on the choice of outcomes in this protocol. We thank Cassie Coleman and Michael Moore for authoring the previous versions of this review. The following people conducted the editorial process for this protocol: Sign-off Editors (final editorial decision): Mark Jones (Bond University, Australia); Mieke van Driel (The University of Queensland, Australia). Managing Editor (provided editorial guidance to authors, edited the review, selected peer reviewers, collated peer reviewer comments): Liz Dooley (Bond University, Australia). Contact Editor (provided valuable comments during the process of updating this review, and recommended an editorial decision): Roger AMJ Damoiseaux (Utrecht University, Netherlands). Statistical Editor (provided comments): Robert S Ware (Menzies Health Institute Queensland, Griffith University, Australia). Copy Editor (copy editing and production): Jenny Bellorini, Cochrane Central Production Service. Peer reviewers (provided comments and recommended an editorial decision): Clinical/content review: T.M.A. van Dongen, MD, PhD (no research affiliation, General Practitioner). Consumer review: Ann Fonfa (President/Volunteer, The Annie Appleseed Project); Sallie Bernard (Consumer). Search review: Justin Clark (Bond University, Australia). Sign-off Editors (final editorial decision): Mark Jones (Bond University, Australia); Mieke van Driel (The University of Queensland, Australia). Managing Editor (provided editorial guidance to authors, edited the review, selected peer reviewers, collated peer reviewer comments): Liz Dooley (Bond University, Australia). Contact Editor (provided valuable comments during the process of updating this review, and recommended an editorial decision): Roger AMJ Damoiseaux (Utrecht University, Netherlands). Statistical Editor (provided comments): Robert S Ware (Menzies Health Institute Queensland, Griffith University, Australia). Copy Editor (copy editing and production): Jenny Bellorini, Cochrane Central Production Service. Peer reviewers (provided comments and recommended an editorial decision): Clinical/content review: T.M.A. van Dongen, MD, PhD (no research affiliation, General Practitioner). Consumer review: Ann Fonfa (President/Volunteer, The Annie Appleseed Project); Sallie Bernard (Consumer). Search review: Justin Clark (Bond University, Australia).
Publisher Copyright:
Copyright © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
PY - 2023/11/28
Y1 - 2023/11/28
N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the benefits and harms of decongestants and antihistamines in the treatment of AOM in children. Specifically, we want to assess the impact of decongestants and antihistamines on the presence of otalgia, the persistence of AOM, the need for or change in antibiotic therapy, severe complications and adverse events. We also want to assess whether there are different effects depending on the method of AOM diagnosis, the age of the children or the co-administration of antibiotics, as well as on the dose, duration and route of administration of the interventions.
AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the benefits and harms of decongestants and antihistamines in the treatment of AOM in children. Specifically, we want to assess the impact of decongestants and antihistamines on the presence of otalgia, the persistence of AOM, the need for or change in antibiotic therapy, severe complications and adverse events. We also want to assess whether there are different effects depending on the method of AOM diagnosis, the age of the children or the co-administration of antibiotics, as well as on the dose, duration and route of administration of the interventions.
U2 - 10.1002/14651858.CD015839
DO - 10.1002/14651858.CD015839
M3 - Article
AN - SCOPUS:85178245552
SN - 1465-1858
VL - 2023
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
IS - 11
M1 - CD015839
ER -